John Maraganore, CEO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 57,884 shares at $63.73 ($3.7M) on 2016-07-19, disclosed to the SEC on 2016-07-21.
Open-market sale of $3.7M ALNY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.73 | 13,571 | $865K | 23.1% |
| 2 | $63.73 | 13,571 | $865K | 23.1% |
| 3 | $64.56 | 1,505 | $97K | 2.6% |
| 4 | $64.56 | 1,505 | $97K | 2.6% |
| 5 | $64.29 | 600 | $39K | 1.0% |
| 6 | $64.29 | 600 |
| $39K |
| 1.0% |
| 7 | $65.56 | 12,057 | $790K | 21.1% |
| 8 | $65.56 | 12,057 | $790K | 21.1% |
| 9 | $66.00 | 2,418 | $160K | 4.3% |
| Total | $64.64 avg | 57,884 | $3.7M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |